Credit Suisse Upgrades Medtronic (MDT)

Credit Suisse reported on Thursday that they have increased their rating for medical technology company, Medtronic, Inc.(MDT).

The firm has upgraded MDT from “Neutral” to “Outperform,” and has given the company a $50 price target. This price target suggests a 11% increase from the stock’s current price of $44.51.

Analysts see the company growing faster than current estimates in the next few quarters.

Medtronic shares were up 57 cents, or 1.3% during premarket trading Thursday. The stock has increased 14% in the past year.

The Bottom Line
Shares of Medtronic (MDT) have a 2.37% dividend yield, based on last night’s closing stock price of $43.94. The stock has technical support in the $40-$41 price area. If the shares can firm up, we see overhead resistance around the $46-$48 price levels.

Medtronic, Inc.(MDT) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here